The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)

RWTH Aachen University

Overview

The aim of the study is to choose an optimal stent and to get further knowledge about the mechanisms of the engraftment of a stent. The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Conditions

Re-stenosis Cirrhosis of the Liver

Interventions

ZESDEVICE

stent implantation (zotarolimus eluting stent)

BMSDEVICE

stent implantation (bare metal stent)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * male and female patients with a severe dysfunction of liver * patient is planned a coronary stent implantation * adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel * written informed consent prior to study participation Exclusion Criteria: * younger than 18 years * pregnancy and breast-feeding * acute cardiac syndrome * contraindication against an intracardiac catheter * persons in dependence from the sponsor or working with the sponsor * participation in a parallel interventional clinical trial * patient has been committed to an institution by legal or regulatory order

Outcomes

Primary Outcomes

the ideal stent (coated stent or uncoated stent)

Time frame: 5 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.